et al. Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial. J Infect Dis (2023) 228(3):299–310. doi: 10.1093/infdis/jiad024
The Food and Drug Administration (FDA) approved the first RSV vaccine for pregnant mothers. It is based on the RSV prefusion F protein (RSVPreF). This article discusses a phase 3 trial that assessed the effects of a maternal RSV vaccine (RSVPreF3-Mat) on extreme RSV-type cases in young...
2. Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV) 3. RSV Vaccines 2023 — Precision Vaccinations 4. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPre-F3) in Mothers and Their Infants: A Phase 2 Randomized Trial 5. A phase 1,rand...
A tragedy in the 1960s set back the whole field. Using the approach that led to the first polio vaccine, scientists made an experimental RSV vaccine by growing the virus in a lab and killing it. But testing in children found not only was the vaccine not protective, youngsters who caught ...
The company's single-dose vaccine is the first RSV treatment to use maternal immunization: Expectant mothers get vaccinated with the shot, which triggers antibodies that are passed to the fetus. That provides infants with protection against the virus from birth through the first six months of ...
Deza Leon hopes that her story will help more mothers want to get the vaccine when it's available. "There's nothing scarier for a parent than seeing your kid struggling to breathe ... I think if you have the opportunity to protect your kids, then you should take it and getting t...
Pfizer said there were no signs of safety problems in mothers or babies. The company said the study showed the vaccine was most effective against severe disease. For milder sickness, the rate of effectiveness dropped to...
Vaccine better protects infants of mothers from LMICs An intriguing finding of the study is that when the analyses were stratified [a method of sampling from a population which can be partitioned into sub-populations] by country income status, the vaccine appeared to be more protective in infants...
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidan
Kansas health care professionals say more education is needed regarding the vaccine for respiratory syncytial virus, or RSV. Kansas Health Institute hosted a v